
Academic Journal
Q2Frontiers in Drug Delivery
About Frontiers in Drug Delivery
Frontiers in Drug Delivery is a scholarly journal published by Frontiers Media SA. SCImago 2025 lists it in Q2, with an SJR of 0.789 and H-index of 13.
Coverage: 2021-2026. Research categories: Clinical Biochemistry (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-03-12. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Advanced Drug Delivery Systems; Nanoparticle-Based Drug Delivery; Inhalation and Respiratory Drug Delivery; Advancements in Transdermal Drug Delivery; RNA Interference and Gene Delivery; Barrier Structure and Function Studies.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Design and optimization of mucoadhesive chitosan microspheres for oesophageal delivery of fluconazole
H. N. Shivakumar, Ayush Parmar, Rushikesh Shinde, Sanjana S. P et al.
2026-10-01 · DOI: 10.3389/fddev.2026.1962873Engineering the oxidative myocardium: ROS-responsive biomaterials for precision cardiovascular delivery in ischemia-reperfusion injury and post-infarction remodeling
Hossein Omidian, Kwadwo A. Mfoafo, Luigi X. Cubeddu
2026-09-16 · DOI: 10.3389/fddev.2026.1929035Correction: A two-tier protection strategy for oral delivery of GLP-1 peptides: lipid-based formulation combined with enteric capsules
Camille Dumont, Vanessa Gonzalez, Paula Klatt, Sandrine Picco et al.
2026-09-15 · DOI: 10.3389/fddev.2026.1973549Synthesis, characterisation, and in vitro assessment of hyaluronic acid-coated solid lipid nanoparticles entrapping dexamethasone palmitate designed for intra-articular administration
Jinxin Zhang, Rumi Khandelia, Bridget Hogg, Ahmad Z. Bahlool et al.
2026-09-04 · DOI: 10.3389/fddev.2026.1809275Hyaluronidase-enhanced delivery in gene therapy and regenerative medicine for improved vector, cell, and cargo access
Patrick E. Sewell, Christopher Jensen
2026-09-03 · DOI: 10.3389/fddev.2026.1906950Case report: Caplacizumab without plasma exchange for severe thrombotic thrombocytopenic purpura
Sarah Maryon Hayes, Daniel F. Pease, Christine M. Wiese, Marshall Mazepa et al.
2026-08-28 · DOI: 10.3389/fddev.2026.1894135Harnessing liposomal delivery to boost polyphenols’ potential in chronic wound therapy
Lisa Myrseth Hemmingsen, Marte Kristensen, Cecilie Thanh Loan Dang, Mari Salamonsen et al.
2026-08-21 · DOI: 10.3389/fddev.2026.1839747Engineering a medical device for intranasal immunisation: ensuring targeted delivery and formulation stability
Gonçalo Farias, Arnaud Bude, Nektaria Karavas, Christelle Rossignol et al.
2026-08-18 · DOI: 10.3389/fddev.2026.1875011The biological memory buffer hypothesis: can programmable nanocarriers shape cellular memory to improve the durability of mRNA vaccines and gene therapies?
Okechukwu Paul-Chima Ugwu, Chinyere Nneoma Ugwu, Godson Emeka Anyanwu, Mariam Basajja et al.
2026-07-24 · DOI: 10.3389/fddev.2026.1902184Microplastics matter: practical implications of the EU REACH restriction for the pharmaceutical industry
Pauline Henrica Maria Janssen, Willem Antoon Rijpkema, Lorina Bisharat, Marlijn Orbons et al.
2026-06-04 · DOI: 10.3389/fddev.2026.1854462Antiparasitic triterpenic ester and ursolic acid lipid nanocapsule design, cytotoxicity, and permeability evaluation for oral delivery
Laura Schioppa, Cecilia Bohns Michalowski, Lucia Mamede, Romano Terrasi et al.
2026-06-03 · DOI: 10.3389/fddev.2026.1846904Phosphosulindac (OXT-328) restores the suppressed corneal sensitivity in rabbits with dry eye disease: therapeutic implications
Wei Huang, Ziyi Wen, Konstantinos Tourmouzis, Liqun Huang et al.
2026-06-03 · DOI: 10.3389/fddev.2026.1778440The fourth controlled release society workshop on oral peptide administration
David J. Brayden, Stephen T. Buckley, Andrew L. Lewis
2026-06-01 · DOI: 10.3389/fddev.2026.1860678A two-tier protection strategy for oral delivery of GLP-1 peptides: lipid-based formulation combined with enteric capsules
Camille Dumont, Vanessa Gonzalez, Paula Klatt, Sandrine Picco et al.
2026-05-22 · DOI: 10.3389/fddev.2026.1770094Variability in the circulation of cerebrospinal fluid: causes and clinical implications for intraventricular drug delivery
Herbert H. Engelhard, Olivier Balédent, Matthew T. Borzage, Lydia Andrews-Jones et al.
2026-05-12 · DOI: 10.3389/fddev.2026.1735474Oral delivery of biologics: from barrier-limited formulation to active convective transport
Sarfaraz K. Niazi
2026-05-04 · DOI: 10.3389/fddev.2026.1783113Analytical similarity as the primary determinant of monoclonal antibody development: toward evidence-efficient regulatory frameworks
Sarfaraz K. Niazi
2026-04-15 · DOI: 10.3389/fddev.2026.1801236Nanoparticle-mediated mRNA delivery for cancer, autoimmunity, and genetic diseases: a rapid review
Okechukwu Paul-Chima Ugwu, Fabian C. Ogenyi, Mariam Basajja, Chinyere N. Ugwu et al.
2026-04-01 · DOI: 10.3389/fddev.2026.1793322Navigating the complexity of oral peptide delivery: challenges and strategies to enhance oral bioavailability
Noor-Ul-Ain Khalid, Edgardo Rivera-Delgado, Thomas von Erlach
2026-03-24 · DOI: 10.3389/fddev.2026.1809842Oral delivery of peptides and proteins: pharmacokinetic boundaries, negative selection, and route triage
Sarfaraz K. Niazi
2026-03-20 · DOI: 10.3389/fddev.2026.1776167Reviews
Community Reviews
Version History
October 4, 2026 at 9:05 pm
October 2, 2026